Why is "Geographic atrophy" trending?
Latest news, Wikipedia summary, and trend analysis.
Trend Analysis
- Ranking position: #
- Date: 2026-03-30 14:13:20
This topic has appeared in the trending rankings 1 time(s) in the past year. While it does not trend frequently, its appearance suggests a renewed or concentrated surge of public interest.
Based on Wikipedia pageviews and search interest, this topic gained significant attention on the selected date.
Trend Insight
Geographic_atrophy entered the ranking for the first time today at position #. This is its highest position ever recorded.
Trend History
This topic has appeared in the English Wikipedia rankings 1 time. It first appeared on 2026-03-30 and was most recently seen on 2026-03-30.
Wikipedia Overview
Geographic atrophy (GA), also known as atrophic age-related macular degeneration (AMD) or advanced dry AMD, is an advanced form of age-related macular degeneration that can result in the progressive and irreversible loss of retinal tissue (photoreceptors, retinal pigment epithelium, choriocapillaris) which can lead to a loss of central vision over time. It is estimated that GA affects over 5 million people worldwide and approximately 1 million patients in the US, which is similar to the prevalence of neovascular (wet) AMD, the other advanced form of the disease.
Read more on Wikipedia →Related Topics
Trending Topic Today
Search Interest Perspective
-
AI model predicts retinal function in geographic atrophy | Eye Care Network - Modern Retina - ophthalmologytimes.com
-
Ocugen's OCU410 Gene Therapy Wins FDA RMAT Designation for Geographic Atrophy - BioPharm International
-
Pegcetacoplan shows visual acuity benefit in geographic atrophy - Healio
-
Ocugen Announces that the U.S. Food and Drug Administration - GlobeNewswire
-
Automated OCT-tailored and same-visit biomarker-targeted microperimetry in geographic atrophy - Nature
-
Q&A: AI-predicted retinal function shows promise in geographic atrophy - ophthalmologytimes.com
-
Microperimetry helps track structure, function in geographic atrophy - Healio
-
ASRS 2026: K8 slows geographic atrophy lesion growth up to 54% in phase 2 | Eye Care Network - Modern Retina - ophthalmologytimes.com
-
Geographic atrophy: When lesion borders cannot be graded | Eye Care Network - Modern Retina - ophthalmologytimes.com
-
Geographic atrophy topography and quality of life: What the central 2.5-mm region reveals - ophthalmologytimes.com
-
ASRS 2026: Margaret Chang, MD, MS, on baseline predictors of vision loss in geographic atrophy - ophthalmologytimes.com
-
Where does the field stand on functional outcomes in geographic atrophy? - ophthalmologytimes.com
-
Which baseline characteristics predict vision loss in geographic atrophy? - ophthalmologytimes.com
-
Retina World Congress 2026: Dry AMD — Geographic atrophy, photobiomodulation, and the road ahead - ophthalmologytimes.com
-
First patient dosed in phase I/II trial of complement-targeting gene therapy for geographic atrophy - ophthalmologytimes.com
-
From detection to decision-making: Navigating disease progression and treatment in geographic atrophy - ophthalmologytimes.com
-
Navigating geographic atrophy from biomarkers to bilateral therapy - ophthalmologytimes.com
-
Pegcetacoplan Does Not Impact Anti-VEGF Treatment in Geographic Atrophy, With Ted Leng, MD, MS - ophthalmologytimes.com
-
Advancing geographic atrophy care: Long-term data and real-world insights - ophthalmologytimes.com
-
The Wills Retina Report: Regillo and Garg on managing geographic atrophy—who, when, and how - ophthalmologytimes.com
-
Seeing what visual acuity misses: Focal microperimetry in geographic atrophy | Eye Care Network - Modern Retina - ophthalmologytimes.com
-
Cost, coverage, and access challenges in geographic atrophy treatment - ophthalmologytimes.com
-
GALE Extension Study: Long-Term Pegcetacoplan Delays Geographic Atrophy Progression - Ophthalmology Advisor
-
Q&A: Beyond complement inhibition in geographic atrophy at COPHy 2026 - ophthalmologytimes.com
-
Permeable nanoreactor eye drop for enzymatic cascade-mediated treatment for acute retinal injury model mimicking geographic atrophy - Nature
-
Specialists navigate changing, challenging landscape of geographic atrophy management - Healio
-
Phase 2 topline data: Ocugen OCU410 reduces geographic atrophy lesion growth by 31% at 12 months - ophthalmologytimes.com
-
Subretinal Photovoltaic Implant to Restore Vision in Geographic Atrophy Due to AMD - The New England Journal of Medicine
-
FDA grants Fast Track Designation to Complement Therapeutics’ CTx001 for geographic atrophy - ophthalmologytimes.com
-
Tips on Slowing Your GA Progression - Cleveland Clinic Health Essentials
-
Inflammasome Therapeutics Reports Positive Six-Month Phase 2 Results for K8 in Geographic Atrophy - biospace.com
-
Patient selection and counseling for complement inhibitor therapy in geographic atrophy - ophthalmologytimes.com
-
Clinical characteristics and progression rates of geographic atrophy in an Asian population from Singapore - Nature
-
IZERVAY® (avacincaptad pegol intravitreal solution) Demonstrated Increased Probability of Maintaining Driving Eligibility in Geographic Atrophy Patients - PR Newswire
-
Can A Retinal Implant Really Restore Vision Lost Due To Geographic Atrophy? - Ophthalmology Advisor
-
Astellas to Highlight New Findings for Geographic Atrophy at ARVO 2026 Annual Meeting - PR Newswire
-
Collaborative Care: A Key to Improving Outcomes in Geographic Atrophy - Review of Optometry
-
Differentiation of macular atrophy secondary to neovascular age-related macular degeneration vs. de novo geographic atrophy: a multimodal analysis | Eye - Nature
-
Restoring Vision for Patients with AMD and Geographic Atrophy - The New England Journal of Medicine
-
Study Raises Questions About Effects, Risks of Drugs for Geographic Atrophy - MedPage Today
-
Current and Emerging Treatments for Geographic Atrophy and When to Initiate Therapy - ophthalmologytimes.com
-
Geographic Atrophy Area Measurements Vary by FAF Device, Wavelength - Review of Optometry
-
Ocugen Announces Positive Preliminary Phase 2 Data from OCU410 Modifier Gene Therapy for Geographic Atrophy Secondary to Dry Age-Related Macular Degeneration - Ocugen, Inc.
-
Geographic Atrophy Structural Measure May Be Predictive of Visual Acuity Decline - Ophthalmology Advisor
-
Annexon to Present Phase 2 ARCHER Baseline Characteristics - GlobeNewswire
-
Aviceda Therapeutics reports positive phase 2b SIGLEC results for AVD-104 in geographic atrophy - ophthalmologytimes.com
-
Science Corp. Announces European Commercial Launch of PRIMA, the Only Treatment to Restore Functional Central Vision to Patients with Geographic Atrophy Caused by Age-Related Macular Degeneration, a Leading Cause of Blindness - Business Wire
-
Seeing Life Differently: Navigating Geographic Atrophy with Resilience - Smithsonian Magazine
-
For GA Treatment, the Earlier the Better - Review of Optometry
-
FDA grants RMAT designation to Ocugen's OCU410 for treating geographic atrophy in dry AMD patients - Pluang
-
New Decision Tool Could Guide Geographic Atrophy Treatment - Review of Optometry
-
Advancing Geographic Atrophy Care: Early Detection, Imaging Innovations, and Evolving Treatment Strategies - ophthalmologytimes.com
-
Ocugen Announces Topline 12-month Data from Phase 2 ArMaDa Clinical Trial Evaluating OCU410 Modifier Gene Therapy for Geographic Atrophy Secondary to Dry Age-Related Macular Degeneration - Ocugen, Inc.
-
IZERVAY® (avacincaptad pegol intravitreal solution) Demonstrated Increased Probability of Maintaining Driving Eligibility in Geographic Atrophy Patients - Yahoo Finance
-
Clinical & Experimental Ophthalmology | RANZCO Journal - Wiley Online Library
-
Managing Fovea-Threatening Bilateral Geographic Atrophy in a Highly Independent 90-Year-Old Patient - ophthalmologytimes.com
-
Accepting a Geographic Atrophy Diagnosis - WebMD
-
Patients With Geographic Atrophy Prioritize Independence and Vision Stability - Ophthalmology Advisor
-
Perilesional FAF Patterns Evolve Over Time in Geographic Atrophy - Review of Optometry
-
Why Geographic Atrophy Treatments Are Approved in the US but Not Europe: The Endpoint Debate Shaping the Future of Geographic Atrophy Drug Development - Syneos Health
-
Aviceda geographic atrophy hopeful fails to top Astellas' med in phase 2 - Fierce Biotech
-
Living Fully with Geographic Atrophy - Golf Digest
-
Low-Vision Aids for Macular Degeneration - Cleveland Clinic Health Essentials
-
Comparison of choroidal hypertransmission and retinal pigment epithelium loss for quantification of geographic atrophy across commonly used SD-OCT devices - Nature
-
VIDEO: New therapies aim to reverse geographic atrophy, improve visual acuity - Healio
-
New-Onset Visual Snow Syndrome Following Prescription of Bupropion in a Patient With Macular Degeneration and Geographic Atrophy - Psychiatrist.com
-
New drug class shows promise for geographic atrophy - Managed Healthcare Executive
-
Photobiomodulation Shows Vision Gains in Dry AMD at 24 Months - Review of Optometry
-
Retinal Implant Restores Vision in Geographic Atrophy - Review of Optometry
-
Joy as retinal implant restores sight in geographic atrophy - pharmaphorum
-
Retinal Implant Restores Vision in Geographic Atrophy - Review of Optometry
-
AAO 2025: A real-world perspective on the use of avacincaptad pegol for geographic atrophy - ophthalmologytimes.com
-
VIDEO: Treatments for geographic atrophy controversial - Healio
-
ASRS 2025: Geographic atrophy on display - ophthalmologytimes.com
-
6 Best Foods for Geographic Atrophy, According to Research - Everyday Health
-
Virtual Reality Tool May Offer Easier Vision Testing, Early Research Shows - CU Anschutz newsroom
-
IZERVAY™ (avacincaptad pegol intravitreal solution) Showed Increased Benefit in Reducing Geographic Atrophy Progression Over Time and Consistent Long-Term Safety - PR Newswire
-
Complement Therapeutics Announces FDA Fast Track Designation for CTx001 for the Treatment of Geographic Atrophy Secondary to AMD - PR Newswire
-
FDA clears IND for Complement Therapeutics’ CTx001 gene therapy in geographic atrophy - ophthalmologytimes.com
-
AREDS Vitamins Show No Effect in Geographic Atrophy - Medscape
-
ONL Therapeutics Announces First European Patient Randomized in its Global Phase 2 GALAXY Trial of Xelafaslatide (ONL1204) in Patients with Geographic Atrophy (GA) Associated with Dry AMD - PR Newswire
-
Aviceda’s geographic atrophy drug fails mid-stage study. Can it do better in Phase 3? - Endpoints News
-
Ocugen sets sights on Phase III after GA gene therapy win - Clinical Trials Arena
-
Geographic Atrophy Market to Surge Significantly During the - GlobeNewswire
-
Izervay continued to show benefit in geographic atrophy in open-label study - Managed Healthcare Executive
-
Aging: Eye implant restores vision loss from irreversible condition - Medical News Today
-
Perilesional FAF Patterns Evolve Over Time in Geographic Atrophy - Review of Optometry
-
Ocugen Announces Topline 12-month Data from Phase 2 ArMaDa - GlobeNewswire
-
Aviceda Therapeutics Announces Phase 2b SIGLEC Results for AVD-104 in Geographic Atrophy - Business Wire
-
Data Presented Shows AREDS Vitamins Don’t Slow Geographic Atrophy in AMD | AAO 2025 - Managed Healthcare Executive
-
Study Supports Earlier Start for Geographic Atrophy Drug - Medscape
-
Signs and Symptoms - Healio
-
Q&A: First time results of VOY-101 for geographic atrophy - ophthalmologytimes.com
-
3 Worst Foods for Geographic Atrophy, According to Research - Everyday Health
-
Apellis Reports 5-Year Data Showing Syfovre Significantly Delays GA Progression - Eyewire+
-
7 Easy Snacks for Geographic Atrophy When You’re on the Go - Everyday Health
-
Real-World Study Shows Positive Pegcetacoplan Results for Geographic Atrophy - Review of Optometry
-
Ocugen to Host Webcast on Tuesday, March 24 at 8 a.m. EDT to Discuss Phase 2 Clinical Trial Data for OCU410—Modifier Gene Therapy for Geographic Atrophy - Yahoo Finance
-
AVD-104 demonstrates anatomic, functional improvements in geographic atrophy - Healio
-
Astellas to Present New Data on IZERVAY™ (avacincaptad pegol intravitreal solution) in Geographic Atrophy at AAO 2025 Annual Meeting - PR Newswire
Why This Topic Is Trending
This topic has recently gained attention due to increased public interest. Search activity and Wikipedia pageviews suggest growing global engagement.
Search Interest & Related Topics
Search interest data over the past 12 months indicates that this topic periodically attracts global attention. Sudden spikes often correlate with major news events, public statements, or geopolitical developments.